Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Jul 15;129(8):3339-3346.
doi: 10.1172/JCI127413.

Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance

Serena Spudich  1 , Kevin R Robertson  2 , Ronald J Bosch  3 , Rajesh T Gandhi  4 , Joshua C Cyktor  5 , Hanna Mar  3 , Bernard J Macatangay  5 , Christina M Lalama  3 , Charles Rinaldo  5 , Ann C Collier  6 , Catherine Godfrey  7 , Joseph J Eron  2 , Deborah McMahon  5 , Jana L Jacobs  5 , Dianna Koontz  5 , Evelyn Hogg  8 , Alyssa Vecchio  2 , John W Mellors  5
Affiliations
Clinical Trial

Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance

Serena Spudich et al. J Clin Invest. .

Abstract

BACKGROUNDPersistence of HIV in sanctuary sites despite antiretroviral therapy (ART) presents a barrier to HIV remission and may affect neurocognitive function. We assessed HIV persistence in cerebrospinal fluid (CSF) and associations with inflammation and neurocognitive performance during long-term ART.METHODSParticipants enrolled in the AIDS Clinical Trials Group (ACTG) HIV Reservoirs Cohort Study (A5321) underwent concurrent lumbar puncture, phlebotomy, and neurocognitive assessment. Cell-associated HIV DNA and HIV RNA (CA-DNA, CA-RNA) were measured by quantitative PCR (qPCR). in peripheral blood mononuclear cells (PBMCs) and in cell pellets from CSF. In CSF supernatant and blood plasma, cell-free HIV RNA was quantified by qPCR with single copy sensitivity, and inflammatory biomarkers were measured by enzyme immunoassay.RESULTSSixty-nine participants (97% male, median age 50 years, CD4 696 cells/mm3, plasma HIV RNA <100 copies/mL) were assessed after a median 8.6 years of ART. In CSF, cell-free RNA was detected in 4%, CA-RNA in 9%, and CA-DNA in 48% of participants (median level 2.1 copies/103 cells). Detection of cell-free CSF HIV RNA was associated with higher plasma HIV RNA (P = 0.007). CSF inflammatory biomarkers did not correlate with HIV persistence measures. Detection of CSF CA-DNA HIV was associated with worse neurocognitive outcomes including global deficit score (P = 0.005), even after adjusting for age and nadir CD4 count.CONCLUSIONHIV-infected cells persist in CSF in almost half of individuals on long-term ART, and their detection is associated with poorer neurocognitive performance.FUNDINGThis observational study, AIDS Clinical Trials Group (ACTG) HIV Reservoirs Cohort Study (A5321), was supported by the National Institutes of Health (NIAID and NIMH).

Keywords: AIDS/HIV; Cellular immune response; Immunology.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: SS and KRR codirect a clinical trial that provides study medication donated by Viiv Healthcare. CG wrote this paper in her capacity as an NIH employee, but the views expressed in this paper do not necessarily represent those of the NIH. JWM is a consultant for Gilead and Merck, and owns share options in Co-Crystal Pharmaceuticals, Inc. EH is employed by a commercial company, Social & Scientific Systems. JJE is a consultant to Gilead Sciences, Merck & Co, Janssen, and ViiV Healthcare. KRR consulted for ViiV Healthcare. ACC is a member of a Data Safety and Monitoring Board for studies sponsored by Merck & Co.

Figures

Figure 1
Figure 1. HIV persistence measures in CSF during ART.
In CSF of individuals on sustained ART started in chronic infection, cell-free HIV RNA was detected in 4% (95% CI: 1%–12%), CA-HIV RNA was detected in 9% (95% CI: 3%–18%), and CA-HIV DNA was detected in 48% (95% CI: 36%–60%). The boxes indicate percentage positive (A). Detection of CA-HIV DNA in CSF cells did not significantly associate with pre-ART CD4 count (B), HIV RNA level (C), CD4/CD8 ratio (D), or years on ART (E), where the boxes indicate median values.
Figure 2
Figure 2. Soluble inflammatory biomarkers in CSF.
CSF sCD163 (A) and CXCL-10 (B) were elevated in CSF in HIV+ compared with HIV- participants. Age at CSF collection associated with levels of multiple biomarkers including sCD163 (C), and lower pre-ART CD4/CD8 ratio predicted higher CSF neopterin (D). Segment inside the box indicates median, box edges represent 25th and 75th percentiles and whiskers 10th and 90th percentiles.
Figure 3
Figure 3. Association between detection of CSF CA-HIV DNA and neuropsychological performance.
GDS, global deficit score. Segment inside the box indicates median, box edges represent 25th and 75th percentiles.
See this image and copyright information in PMC

Comment in

References

    1. Churchill MJ, Deeks SG, Margolis DM, Siliciano RF, Swanstrom R. HIV reservoirs: what, where and how to target them. Nat Rev Microbiol. 2016;14(1):55–60. doi: 10.1038/nrmicro.2015.5. - DOI - PubMed
    1. Gray LR, Roche M, Flynn JK, Wesselingh SL, Gorry PR, Churchill MJ. Is the central nervous system a reservoir of HIV-1? Curr Opin HIV AIDS. 2014;9(6):552–558. doi: 10.1097/COH.0000000000000108. - DOI - PMC - PubMed
    1. Estes JD, et al. Defining total-body AIDS-virus burden with implications for curative strategies. Nat Med. 2017;23(11):1271–1276. doi: 10.1038/nm.4411. - DOI - PMC - PubMed
    1. Lamers SL, et al. HIV DNA Is frequently present within pathologic tissues evaluated at autopsy from combined antiretroviral therapy-treated patients with undetectable viral loads. J Virol. 2016;90(20):8968–8983. doi: 10.1128/JVI.00674-16. - DOI - PMC - PubMed
    1. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986;19(6):517–524. doi: 10.1002/ana.410190602. - DOI - PubMed

Publication types